Clinical Trials Browser

Phase 2 × Anorexia × 1 year × Clear all

NCT05546476 2026-06-03

PROACC-1

Phase 2 Completed

187 enrolled 24 charts

GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT07565415 2026-05-04

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

Phase 2 Not yet recruiting

Gastrointestinal

Anorexia, Cachexia, Carcinoma, Hepatocellular, Malnutrition

NCT00488072 2026-01-26

Effects of Mirtazapine on Appetite in Advanced Cancer Patients

Phase 2 Active not recruiting

Anorexia, Sleep Initiation and Maintenance Disorders, Weight Loss

NCT05705492 2026-01-21

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Phase 2 Recruiting

Gastrointestinal

Anorexia, Cachexia, Esophageal Neoplasms, Neoplasms, Colorectal Neoplasms, Weight Loss

NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Phase 2 Terminated

4 enrolled 12 charts

Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

NCT00489307 2025-11-12

Dexamethasone for Symptom Burden in Advanced Cancer Patients

Phase 2 Active not recruiting

132 enrolled 15 charts

Anorexia, Fatigue, Nausea, Pain